The executive order on DNA regulation is limited to institutions receiving federal funds, requiring them to buy DNA from certified companies. However, startups and non-federally funded entities are not covered by the order. There is uncertainty on whether companies will be forced to enhance screening standards. The order also does not apply to DNA providers, necessitating Congress to close these loopholes and improve the executive order, including addressing the Select Agent Program loophole.